BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22824184)

  • 1. Serum IgG responses against Aspergillus proteins before hematopoietic stem cell transplantation or chemotherapy identify patients who develop invasive aspergillosis.
    Du C; Wingard JR; Cheng S; Nguyen MH; Clancy CJ
    Biol Blood Marrow Transplant; 2012 Dec; 18(12):1927-34. PubMed ID: 22824184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Aspergillus immunoglobulin-G testing in serum of hematopoietic stem cell transplant recipients.
    Erdmann JH; Graf B; Blau IW; Fischer F; Timm G; Hemmati P; Arnold R; Penack O
    Transpl Infect Dis; 2016 Jun; 18(3):354-60. PubMed ID: 26998687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibody detection in patients with invasive aspergillosis].
    Kappe R; Rimek D
    Mycoses; 2004; 47 Suppl 1():55-9. PubMed ID: 15667366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia.
    Halliday C; Hoile R; Sorrell T; James G; Yadav S; Shaw P; Bleakley M; Bradstock K; Chen S
    Br J Haematol; 2006 Feb; 132(4):478-86. PubMed ID: 16412020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive Aspergillus infections in allo-SCT recipients: environmental sampling, nasal and oral colonization and galactomannan testing.
    Nihtinen A; Anttila VJ; Richardson M; Ruutu T; Juvonen E; Meri T; Volin L
    Bone Marrow Transplant; 2010 Feb; 45(2):333-8. PubMed ID: 19617902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
    Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections.
    Stuehler C; Nowakowska J; Bernardini C; Topp MS; Battegay M; Passweg J; Khanna N
    J Infect Dis; 2015 Apr; 211(8):1251-61. PubMed ID: 25367298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serological diagnosis of pulmonary aspergillosis--measurement of IgG-, IgM- and IgA- antibodies against Aspergillus fumigatus by means of ELISA].
    Ninomiya H; Harada S; Harada Y; Takamoto M; Ishibashi T; Shinoda A
    Kekkaku; 1990 Apr; 65(4):263-72. PubMed ID: 2198374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
    Labbé AC; Su SH; Laverdière M; Pépin J; Patiño C; Cohen S; Kiss T; Lachance S; Sauvageau G; Busque L; Roy DC; Roy J
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1192-200. PubMed ID: 17889356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
    Armenian SH; Nash KA; Kapoor N; Franklin JL; Gaynon PS; Ross LA; Hoffman JA
    J Pediatr Hematol Oncol; 2009 Dec; 31(12):920-6. PubMed ID: 19855303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients.
    Oshima K; Kanda Y; Asano-Mori Y; Nishimoto N; Arai S; Nagai S; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
    J Antimicrob Chemother; 2007 Aug; 60(2):350-5. PubMed ID: 17584800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients.
    Choi SH; Kang ES; Eo H; Yoo SY; Kim JH; Yoo KH; Sung KW; Koo HH; Kim YJ
    Pediatr Blood Cancer; 2013 Feb; 60(2):316-22. PubMed ID: 23042761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis.
    Kontoyiannis DP; Ratanatharathorn V; Young JA; Raymond J; Laverdière M; Denning DW; Patterson TF; Facklam D; Kovanda L; Arnold L; Lau W; Buell D; Marr KA
    Transpl Infect Dis; 2009 Feb; 11(1):89-93. PubMed ID: 18983417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers.
    Cordonnier C; Ribaud P; Herbrecht R; Milpied N; Valteau-Couanet D; Morgan C; Wade A;
    Clin Infect Dis; 2006 Apr; 42(7):955-63. PubMed ID: 16511759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.
    Blennow O; Remberger M; Klingspor L; Omazic B; Fransson K; Ljungman P; Mattsson J; Ringdén O
    Bone Marrow Transplant; 2010 Dec; 45(12):1710-8. PubMed ID: 20190840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant antigens as diagnostic markers for aspergillosis.
    Sarfati J; Monod M; Recco P; Sulahian A; Pinel C; Candolfi E; Fontaine T; Debeaupuis JP; Tabouret M; Latgé JP
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):279-91. PubMed ID: 16626916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Platelia Aspergillus enzyme immunoassay for the diagnosis of invasive aspergillosis.
    Lai CC; Hsu HL; Lee LN; Hsueh PR
    J Microbiol Immunol Infect; 2007 Apr; 40(2):148-53. PubMed ID: 17446963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation and Association With Occurrence and Outcome of Invasive Aspergillosis.
    Stuehler C; Kuenzli E; Jaeger VK; Baettig V; Ferracin F; Rajacic Z; Kaiser D; Bernardini C; Forrer P; Weisser M; Elzi L; Battegay M; Halter J; Passweg J; Khanna N
    J Infect Dis; 2015 Sep; 212(6):959-67. PubMed ID: 25748323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using the galactomannan antigen assay in the diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation.
    Tănase AD; Coliţă A; Mărculescu A; Berteanu C; Streinu Cercel A; Stoica M; Stoica A; Cernea D; Copotoiu S; Brînzaniuc K; Azamfirei L
    Rom J Morphol Embryol; 2012; 53(2):379-82. PubMed ID: 22732810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.